Source: Eur Respir Rev 2013; 22: 376-381
Disease area: Interstitial lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Mini Philip L. Molyneaux, Toby M. Maher. The role of infection in the pathogenesis of idiopathic pulmonary fibrosis},. Eur Respir Rev 2013; 22: 376-381

Member's Comments

No comment yet.

Related content which might interest you: The role of viruses in the pathogenesis of pulmonary fibrosis Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease Year: 2021 Does interferon-γ improve pulmonary function in idiopathic pulmonary fibrosis? Source: Eur Respir J 2003 Dec 01;22(6):906-911 Year: 2003 Pathogenesis of idiopathic pulmonary fibrosis: role of neutrophil inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 102s Year: 2006 Common pathways in idiopathic pulmonary fibrosis and cancer}, Source: Eur Respir Rev 2013; 22: 265-272 Year: 2013 Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Source: Eur Respir J 2007; 30: 835-839 Year: 2007 The pathogenesis of pulmonary fibrosis: a moving target Source: Eur Respir J 2013; 41: 1207-1218 Year: 2013 Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis Source: Eur Respir J 2016; 48: 538-552 Year: 2016 PAH and inflammation: its role in pathogenesis - is it of value to modulate it? Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension Year: 2005 A role for cathepsin S in the pathogenesis of cystic fibrosis lung disease? Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 The clinical relevance of autoimmunity in idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Increased endothelial and epithelial apoptosis play a central role in the pathogenesis of systemic sclerosis and idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Idiopathic pulmonary fibrosis (IPF): epidemiology, biology, diagnosis and treatment Source: Virtual Congress 2020 – When the lung gets stiff Year: 2020 Pulmonary hypertension in chronic interstitial lung diseases}, Source: Eur Respir Rev 2013; 22: 292-301 Year: 2013 Unfolding the mechanisms of progression of pulmonary emphysema in COPD}, Source: Eur Respir J 2012; 40: 801-803 Year: 2012 Low telomerase expression in alveolar epithelial plays a role in the pathogenesis of idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Pulmonary arterial hypertension in end-stage idiopathic pulmonary fibrosis: a hypothetic role for viral infections Source: Annual Congress 2009 - Pulmonary arterial hypertension Year: 2009 Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future}, Source: Eur Respir Rev 2013; 22: 281-291 Year: 2013 The role of systemic markers of inflammation in bronchiectasis. Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Mechanisms of treatment response to pirfenidone of idiopathic pulmonary fibrosis (IPF) patients Source: International Congress 2016 – IPF pathogenesis Year: 2016